Research organizations have engineered an advanced ocular implant system, named Prima, specifically designed to counteract vision loss among the elderly population stemming from age - related macular degeneration. This system is composed of two key components: a 2mm×2mm subretinal implant and a pair of augmented reality glasses.

The implant is meticulously positioned beneath the retina through a surgical procedure. Its primary function is to take over the role of the damaged photoreceptor cells. Meanwhile, the augmented reality glasses are outfitted with a microcamera that captures real - world images. These captured images then undergo processing by sophisticated algorithms. Subsequently, they are transformed into infrared beams and projected onto the implant device. This projection stimulates the retinal neurons, which in turn transmit the visual information to the brain.

Clinical trials have yielded promising results. Out of the 38 patients involved, 81% witnessed a substantial improvement in their vision after the implantation. On average, they were able to recognize 23 additional letters, which roughly equates to 4.6 lines on a standard eye chart. Some patients even managed to achieve a visual acuity of 20/63 by utilizing the zoom function of the system.

In terms of safety, the system has proven to be quite reliable. One year after the surgery, the patients' natural vision remained stable. Moreover, only five patients did not show any improvement in their vision.

This groundbreaking technology marks the first viable solution for restoring the ability to read fluently in patients suffering from dry age - related macular degeneration. As such, it holds immense clinical significance.